Close Menu

NEW YORK (GenomeWeb News) – Plant genomics firm Evogene plans to go public in the US with an initial public offering of up to $60 million.

The company, which trades on the Tel Aviv Stock Exchange, filed to go public with the US Securities and Exchange Commission late on Monday, saying it plans to list on the New York Stock Exchange under ticker symbol "EVGN."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

In Science this week: chromatin accessibility of microglia during fetal development, and more.